Home

ducha Vaticinador adecuado lon gsk dividend declarar Microordenador Agente de mudanzas

GlaxoSmithKline (LON:GSK) Could Be A Buy For Its Upcoming Dividend
GlaxoSmithKline (LON:GSK) Could Be A Buy For Its Upcoming Dividend

GSK share price | GSK
GSK share price | GSK

Dividend calendar | GSK
Dividend calendar | GSK

GlaxoSmithKline: 4.57% Dividend Yield, Cure For COVID-19 & HIV | Seeking  Alpha
GlaxoSmithKline: 4.57% Dividend Yield, Cure For COVID-19 & HIV | Seeking Alpha

Glaxo GSK Dividend Cut, Consumer Unit Spinoff via LSE, ADR Listing Planned  - Bloomberg
Glaxo GSK Dividend Cut, Consumer Unit Spinoff via LSE, ADR Listing Planned - Bloomberg

GSK Dividend Yield 2022, Date & History (GSK) - MarketBeat
GSK Dividend Yield 2022, Date & History (GSK) - MarketBeat

GlaxoSmithKline (LON:GSK) Could Be A Buy For Its Upcoming Dividend
GlaxoSmithKline (LON:GSK) Could Be A Buy For Its Upcoming Dividend

Why the GlaxoSmithKline dividend makes me nervous | The Motley Fool UK
Why the GlaxoSmithKline dividend makes me nervous | The Motley Fool UK

Stock exchange announcements | GSK
Stock exchange announcements | GSK

GSK shareholders clear way for consumer health unit Haleon spinoff |  Seeking Alpha
GSK shareholders clear way for consumer health unit Haleon spinoff | Seeking Alpha

GSK consumer business split off after investor pressure from Elliott  Management
GSK consumer business split off after investor pressure from Elliott Management

GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022

Pfizer to exit GSK consumer health joint venture after London listing |  Financial Times
Pfizer to exit GSK consumer health joint venture after London listing | Financial Times

Emma Walmsley slashes dividend in radical shake-up to save her job
Emma Walmsley slashes dividend in radical shake-up to save her job

GlaxoSmithKline: Robust Pipeline Supports Its 5.5% Dividend Yield (NYSE:GSK)  | Seeking Alpha
GlaxoSmithKline: Robust Pipeline Supports Its 5.5% Dividend Yield (NYSE:GSK) | Seeking Alpha

GSK investor support for spin-off vindicates rejection of Unilever bid,  says chief | Financial Times
GSK investor support for spin-off vindicates rejection of Unilever bid, says chief | Financial Times

GlaxoSmithKline hopes for boost from respiratory virus jab | Financial Times
GlaxoSmithKline hopes for boost from respiratory virus jab | Financial Times

GlaxoSmithKline (GSK) Just Announced a Dividend Cut. Why Its Stock Is  Rising. | Barron's
GlaxoSmithKline (GSK) Just Announced a Dividend Cut. Why Its Stock Is Rising. | Barron's

Stock exchange announcements | GSK
Stock exchange announcements | GSK

Is it still worth buying GlaxoSmithKline shares after its Haleon spin off?  | MoneyWeek
Is it still worth buying GlaxoSmithKline shares after its Haleon spin off? | MoneyWeek

GSK Plc (GSK) Dividends
GSK Plc (GSK) Dividends

GSK Plc (GSK) Dividends
GSK Plc (GSK) Dividends

GSK shares rise on strong revenues and dividend commitment | Financial Times
GSK shares rise on strong revenues and dividend commitment | Financial Times

Manage your shares | GSK
Manage your shares | GSK

Is GlaxoSmithKline plc's (LON:GSK) 4.8% Dividend Worth Your Time?
Is GlaxoSmithKline plc's (LON:GSK) 4.8% Dividend Worth Your Time?

How will GSK shareholders get their Haleon stock? GlaxoSmithKline spin-off  trading as HLN
How will GSK shareholders get their Haleon stock? GlaxoSmithKline spin-off trading as HLN

GSK Demerger – What You Need To Know About Haleon (HLN) – Forbes Advisor UK
GSK Demerger – What You Need To Know About Haleon (HLN) – Forbes Advisor UK